SEC Form 4 · accession 0001179110-15-000070
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claudia de Oliveira Ribeiro Hirawat
Officer — President
Period of report
Dec 31, 2014
Accepted (ET)
Jan 2, 2015 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2014 | M | 417 | $10.85 | A | 39,417 | D | |
| Common StockF2 | Dec 31, 2014 | S | 417 | $52.39 | D | 39,000 | D | |
| Common Stock | holding | — | — | — | 194 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $10.85 | Dec 31, 2014 | M | 417 | D | — | May 15, 2023 | Common Stock | 417 | 10,000 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.27 to $52.60 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Pursuant to the Separation and General Release Agreement dated December 16, 2014 between the Reporting Person and the Issuer, the remaining options will vest on January 16, 2015.